
Accuray CEO LaNeve called fiscal 2026 an important year on the Q4 call. Full-year revenue and profit figures were not detailed in the prepared remarks.
Accuray (ARAY) held its fiscal fourth-quarter earnings call on Aug. 19, the company said. CEO Stephen LaNeve opened the session by calling fiscal 2026 “an important year” for the radiation oncology equipment maker, though the prepared remarks did not immediately detail revenue or profit figures.
The call, which covered the period ended June 30, included CFO Ali Pervaiz and Vice President of FP&A Stephen Monroe. Management discussed recent corporate developments and reviewed financial results, according to the transcript. Monroe reminded listeners that forward-looking statements carry risks outlined in the company's SEC filings.
LaNeve’s comment that fiscal 2026 was “an important year” came without elaboration in the available portion of the call. The company has not yet released its full-year earnings release or supplemental slides, which were referenced as available on the investor relations website.
Accuray designs and sells the CyberKnife and TomoTherapy systems, competing with Varian Medical Systems and Elekta in the global radiotherapy market. The company’s fiscal year ends June 30. Investors will be watching for the actual revenue and order numbers when the full release becomes available.
The call included the standard caution about forward-looking statements and a mention of non-GAAP financial measures. No specific guidance or segment performance was disclosed in the opening remarks.
Prepared with AlphaScala editorial tooling from the source reporting linked above. Indexable analysis may include a cited Alpha Score value. Publishing checks screen each story before release. Educational coverage, not personalized advice.